Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,663,636
-$3,845 QoQ
Shares Held
155,480
+2.9% QoQ
Ownership
0.784%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 131 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,320 across 417 Biotechnology names. KROS ranks #110 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in KROS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,663,636 | 155,480 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,667,481 | 151,040 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $667,034 | 32,762 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $409,579 | 25,890 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $292,965 | 21,945 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $170,966 | 16,778 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $240,742 | 15,208 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $641,963 | 11,055 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $526,417 | 11,519 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $616,255 | 9,309 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $236,412 | 5,946 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $485,787 | 15,238 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $856,758 | 21,323 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $610,908 | 14,307 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,256 | 47 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $25,016 | 665 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $115,409 | 4,177 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $80,644 | 1,483 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $399,857 | 6,834 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $118 | 3 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $382 | 9 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $26,528 | 431 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,376,516 | 19,514 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $482,973 | 12,522 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $450,982 | 12,023 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||